Navigation Links
FDA Approves Lamictal(R) ODT(TM) Orally Disintegrating Tablets
Date:5/11/2009

ars of age have a higher chance of getting this serious skin reaction while taking Lamictal.

The risk of getting a rash is higher if taking Lamictal while taking valproate (Depakene(R) (valproic acid) or Depakote(R) (divalproex sodium)), taking a higher starting dose of Lamictal than a healthcare provider prescribed or increasing the dose of Lamictal faster than prescribed.

Lamictal can also cause other types of allergic reactions or serious problems which may affect organs and other parts of your body like the liver or blood cells. The patient may or may not have a rash with these types of reactions.

The patient should call their healthcare provider right away if they have any of the following: a skin rash, hives, fever, swollen lymph glands, painful sores in the mouth or around the eyes, swelling of the lips or tongue, yellowing of the skin or eyes, unusual bruising or bleeding, severe fatigue or weakness, severe muscle pain or frequent infections. These symptoms may be the first signs of a serious reaction. A healthcare provider should examine the patient to decide if they should continue taking Lamictal.

Antiepileptic drugs, including Lamictal, increase the risk of suicidal thoughts or behavior in patients taking these drugs for any indication. Patients treated with any antiepileptic drug for any indication should be monitored for the emergence or worsening of depression, suicidal thoughts or behavior, or any unusual changes in mood or behavior.

Patients, their caregivers, and families should be informed that antiepileptic drugs increase the risk of suicidal thoughts and behavior and should be advised of the need to be alert for the emergence or worsening of the signs and symptoms of depression, any unusual changes in mood or behavior, or the emergence of suicidal thoughts, behavior, or thoughts about self-harm. Behavi
'/>"/>

SOURCE GlaxoSmithKline
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6

Related medicine news :

1. Video: FDA approves Exforge HCT(R) - the Only High Blood Pressure Treatment to Combine Three Medications in a Single Pill
2. Kaiser Permanente Approves $13 Million in Community Benefit Grants in First Quarter of 2009
3. FDA Approves Plan B Pill for 17-Year-Olds
4. AUDIO from Medialink and Forest Pharmaceuticals: FDA Approves Lexapro for Major Depressive Disorder in Adolescents
5. AUDIO from Medialink and Forest Pharmaceuticals: FDA Approves Lexapro for Major Depressive Disorder in Adolescents
6. FDA Approves New Indication for Wyeths TYGACIL (tigecycline) for the Treatment of Adult Patients with Community-Acquired Bacterial Pneumonia
7. U.S. FDA Approves New THERAKOS(TM) CELLEX(TM) Photopheresis System
8. FDA Approves Symbyax(R) as First Medication for Treatment-Resistant Depression
9. FDA Approves Two Hologic HPV Tests
10. U.S. Food and Drug Administration Approves New Female Condom
11. Congress Approves FY2009 Omnibus Appropriations Bill with $900 Million for The Global Fund
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/27/2014)... What’s next for 14 year old Sriram ... National Spelling Bee? Sririam will visit Philadelphia on Friday, ... Wills Eye Hospital.     , The teen from Painted Post, ... day. , Wills Eye Ophthalmologist-in-Chief, Dr. Julia Haller will ... visual diagnostic testing. He will also tour historic ...
(Date:8/27/2014)... Amy Norton HealthDay ... People who take part in clinical trials of new heart ... heart patient, a new study confirms. Experts said the ... the American Medical Association , aren,t surprising -- but they ... are enrolling a more select patient population that is not ...
(Date:8/27/2014)... August 27, 2014 Tejal K. Gandhi, MD, ... (NPSF) and the NPSF Lucian Leape Institute, is among ... August 25 issue of Modern Healthcare magazine. Also on the ... Andrew Sussman, MD, MBA; NPSF Lucian Leape Institute members ... who is a member of both the Institute and the ...
(Date:8/27/2014)... Silver Spring and Germantown, Md., and Denver (PRWEB) August ... healthcare real estate developer , has broken ground ... on the new Holy Cross Health hospital campus in ... of Bethesda, Md. Germantown is the third most populous ... medical office building on the Holy Cross Germantown Hospital ...
(Date:8/27/2014)... a parent wants to deal with, but it,s unfortunately ... old. , Skin that turns yellow can be a ... adequately eliminating the chemical bilirubin. But that discoloration is ... can harm a baby. , University of Washington engineers ... for jaundice in newborns and can deliver results to ...
Breaking Medicine News(10 mins):Health News:Scripps National Spelling Bee Co-Champion and Aspiring Ophthalmologist Coming to Wills Eye Hospital in Philadelphia 2Health News:Heart Studies Don't Reflect Real-World Patients, Study Finds 2Health News:Heart Studies Don't Reflect Real-World Patients, Study Finds 3Health News:NPSF President Among 100 Most Influential in Health Care 2Health News:NPSF President Among 100 Most Influential in Health Care 3Health News:NexCore Breaks Ground on Medical Office Building on Holy Cross Health Campus in Germantown, Maryland 2Health News:NexCore Breaks Ground on Medical Office Building on Holy Cross Health Campus in Germantown, Maryland 3Health News:NexCore Breaks Ground on Medical Office Building on Holy Cross Health Campus in Germantown, Maryland 4Health News:New smartphone app can detect newborn jaundice in minutes 2Health News:New smartphone app can detect newborn jaundice in minutes 3
... , , , , ... Outstanding Debt to be Reduced by Approximately $54.8 Million , ... , Company to Book Approximately $8.2 Million Estimated ... by Approximately $45.4 Million , , , , ...
... ... been among the first to use NeoPlas Innovation,s new protocol. , ... Nashville, Tenn. (Vocus) June 16, 2009 -- With an ... his cancer steadily regressing on a new outpatient treatment. Individuals from 26 U.S. states and ...
... as Unwarranted, Withdraws Two Cold Remedy Nasal Products Citing Commitment ... June 16 Matrixx Initiatives, Inc. (Nasdaq: MTXX ... from the U.S. Food and Drug Administration about two of ... Gel and Zicam Cold Remedy Swabs. The warning letter cited ...
... CHICAGO, June 16 David O. Barbe, M.D., a ... the Board of Trustees of the American Medical Association. , ... , , "I am honored to be elected to the ... representing physicians as the AMA and the nation focus on health-care ...
... change" says new leader of American medicine , , ... cardiologist from Bryan, Texas, was inaugurated today as the 164th ... and most influential physician organization. , , (Logo: ... In his inaugural address as AMA president, Dr. Rohack spoke ...
... Food and Drug Administration (FDA) today advised consumers to stop ... cold remedies under the Zicam(R) brand because the use of ... of smell (a condition called anosmia ). ... zinc ingredient, The Quigley Corporation (Nasdaq: QGLY ), ...
Cached Medicine News:Health News:Cell Therapeutics Announces Preliminary Results of its Fixed Price Exchange Offers for Any and All of its $118.9 Million Convertible Notes Outstanding 2Health News:Cell Therapeutics Announces Preliminary Results of its Fixed Price Exchange Offers for Any and All of its $118.9 Million Convertible Notes Outstanding 3Health News:Cell Therapeutics Announces Preliminary Results of its Fixed Price Exchange Offers for Any and All of its $118.9 Million Convertible Notes Outstanding 4Health News:Inoperable Colon Cancer Responds to New Treatment 2Health News:Matrixx Initiatives Voluntarily Withdraws Zicam Cold Remedy Swabs, Zicam Cold Remedy Nasal Gel 2Health News:Matrixx Initiatives Voluntarily Withdraws Zicam Cold Remedy Swabs, Zicam Cold Remedy Nasal Gel 3Health News:AMA Inaugurates J. James Rohack as President 2Health News:Cold-EEZE(R) Lozenges not Affected by FDA Advisory for Zicam(R) Intra-Nasal Products 2Health News:Cold-EEZE(R) Lozenges not Affected by FDA Advisory for Zicam(R) Intra-Nasal Products 3
(Date:8/27/2014)... , Aug. 27, 2014 Ambit Biosciences (Nasdaq: ... development of drugs targeting unmet needs in oncology, autoimmune and ... 2014 Health Care Conference to be held at The New ... on September 3-4, 2014. Alan Fuhrman ... and its lead drug candidate, quizartinib, at 1:10 p.m. ET ...
(Date:8/27/2014)... , Aug. 27, 2014 IRIDEX Corporation (NASDAQ: ... James H. Mackaness is scheduled to make an investor ... at 2:55 p.m. Eastern Time on Wednesday, September 3, in ... of the investor presentation will be available in the Investors ... About IRIDEX IRIDEX Corporation was founded ...
(Date:8/27/2014)... 27, 2014 Sinovac Biotech Ltd. (NASDAQ: SVA ... , today announced the results of the Company,s 2014 Annual ... Beijing , PRC. The required quorum, a majority ... The Company,s shareholders approved the following proposals:  , ... , Simon Anderson , Kenneth Lee and ...
Breaking Medicine Technology:Ambit Announces Participation At Baird 2014 Health Care Conference 2Sinovac Announces Results of 2014 Annual General Meeting of Shareholders 2
... Misonix, Inc. (NASDAQ: MSON ), a ... innovative therapeutic ultrasonic products worldwide for wound debridement, ... other surgical and medical applications, has entered into ... Solutions Australasia Pty. Ltd., based in Newport, Victoria, ...
... Aug. 12, 2011 Southern Research Institute today announced ... named Vice President of the Drug Discovery Division. Dr. ... research and target identification and lead discovery ... diseases and neurological diseases and disorders. ...
Cached Medicine Technology:Misonix Announces New Distribution Agreement for Australia and New Zealand 2Misonix Announces New Distribution Agreement for Australia and New Zealand 3Southern Research Names Mark Suto Vice President of Drug Discovery 2
... ARUP Laboratories is a national reference ... laboratory research and development. ARUP offers an ... unique medical tests in clinical and anatomic ... ARUP Laboratories' clients include more than half ...
... reference laboratory and a worldwide leader in ... an extensive test menu of highly complex ... anatomic pathology. Owned by the University of ... half of the nation's university teaching hospitals ...
... Laboratories is a national reference laboratory and ... and development. ARUP offers an extensive test ... tests in clinical and anatomic pathology. Owned ... clients include more than half of the ...
... national reference laboratory and a worldwide leader ... offers an extensive test menu of highly ... and anatomic pathology. Owned by the University ... than half of the nation's university teaching ...
Medicine Products: